The system reported revenues of $2.9 billion for the year ended June 30, up from $2.6 billion over the same period last year. Net patient service revenues were $2.8 billion, up from $2.5 billion in 2023. Outpatient revenues increased by $149 million year over year, largely driven by the performance of its specialty and retail pharmacies, according to the report. Inpatient and physician revenues increased by $62 million and $28.5 million respectively, driven by higher volumes.
Temple reported total expenses of $2.9 billion in 2024, up from $2.6 billion last year. Salaries and employee benefit expenses totaled $1.53 billion, up from $1.46 billion in 2023. Supply and pharmaceutical costs were $672.8 million in 2024, up from $598.3 million over the same period last year.
Days of cash on hand was 124, as of June 30, down from 126 on the same date in 2023.
Temple reported a net income of $79.1 million in 2024, up from $6.3 million last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
